MARINA PLON: Open Payments
NPI 1366531667 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,283 in 95 payments from 20 companies in 2025. Trend: 2023 $2,333 · 2024 $1,491 · 2025 $2,283
Food & beverage: $2,194Education: $89
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $330 |
| Abbott Laboratories | 5 | $254 |
| PFIZER INC. | 12 | $239 |
| BridgeBio Pharma, Inc. | 8 | $229 |
| Actelion Pharmaceuticals US, Inc. | 5 | $176 |
| Amgen Inc. | 17 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $123 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| E.R. Squibb & Sons, L.L.C. | 5 | $110 |
| Boston Scientific Corporation | 5 | $104 |
Products named: CARDIOMEMS, WINREVAIR, Attruby, REPATHA, VYNDAQEL, JARDIANCE, ELIQUIS, LEQVIO.
Industry payments across NV — which companies pay providers there.
